Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb Revenue 2010-2023 | BMY

Bristol Myers Squibb annual/quarterly revenue history and growth rate from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Bristol Myers Squibb revenue for the quarter ending June 30, 2023 was $11.226B, a 5.56% decline year-over-year.
  • Bristol Myers Squibb revenue for the twelve months ending June 30, 2023 was $45.187B, a 4.15% decline year-over-year.
  • Bristol Myers Squibb annual revenue for 2022 was $46.159B, a 0.49% decline from 2021.
  • Bristol Myers Squibb annual revenue for 2021 was $46.385B, a 9.09% increase from 2020.
  • Bristol Myers Squibb annual revenue for 2020 was $42.518B, a 62.62% increase from 2019.
  
Bristol Myers Squibb Annual Revenue
(Millions of US $)
2022 $46,159
2021 $46,385
2020 $42,518
2019 $26,145
2018 $22,561
2017 $20,776
2016 $19,427
2015 $16,560
2014 $15,879
2013 $16,385
2012 $17,621
2011 $21,244
2010 $19,484
2009 $18,808
Bristol Myers Squibb Quarterly Revenue
(Millions of US $)
2023-06-30 $11,226
2023-03-31 $11,337
2022-12-31 $11,406
2022-09-30 $11,218
2022-06-30 $11,887
2022-03-31 $11,648
2021-12-31 $11,985
2021-09-30 $11,624
2021-06-30 $11,703
2021-03-31 $11,073
2020-12-31 $11,068
2020-09-30 $10,540
2020-06-30 $10,129
2020-03-31 $10,781
2019-12-31 $7,945
2019-09-30 $6,007
2019-06-30 $6,273
2019-03-31 $5,920
2018-12-31 $5,973
2018-09-30 $5,691
2018-06-30 $5,704
2018-03-31 $5,193
2017-12-31 $5,449
2017-09-30 $5,254
2017-06-30 $5,144
2017-03-31 $4,929
2016-12-31 $5,243
2016-09-30 $4,922
2016-06-30 $4,871
2016-03-31 $4,391
2015-12-31 $4,287
2015-09-30 $4,069
2015-06-30 $4,163
2015-03-31 $4,041
2014-12-31 $4,258
2014-09-30 $3,921
2014-06-30 $3,889
2014-03-31 $3,811
2013-12-31 $4,441
2013-09-30 $4,065
2013-06-30 $4,048
2013-03-31 $3,831
2012-12-31 $4,191
2012-09-30 $3,736
2012-06-30 $4,443
2012-03-31 $5,251
2011-12-31 $5,454
2011-09-30 $5,345
2011-06-30 $5,434
2011-03-31 $5,011
2010-12-31 $5,111
2010-09-30 $4,798
2010-06-30 $4,768
2010-03-31 $4,807
2009-12-31 $5,033
2009-09-30 $4,788
2009-06-30 $4,665
2009-03-31 $4,322
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $122.797B $46.159B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $145.204B 15.28
Gilead Sciences (GILD) United States $94.473B 12.07
Vertex Pharmaceuticals (VRTX) United States $90.929B 26.79
Regeneron Pharmaceuticals (REGN) United States $90.280B 21.79
CSL (CSLLY) Australia $82.015B 0.00
GSK (GSK) United Kingdom $77.949B 10.57
Moderna (MRNA) United States $39.403B 38.20
Seagen (SGEN) United States $38.852B 0.00
Biogen (BIIB) United States $37.731B 16.04
Argenex SE (ARGX) Netherlands $30.089B 0.00
Horizon Therapeutics Public (HZNP) Ireland $26.472B 25.75
BioNTech SE (BNTX) Germany $26.174B 6.09
Genmab (GMAB) Denmark $24.725B 37.43
Alnylam Pharmaceuticals (ALNY) United States $21.940B 0.00
Illumina (ILMN) United States $21.901B 157.22
BeiGene (BGNE) Cayman Islands $18.676B 0.00
BioMarin Pharmaceutical (BMRN) United States $16.631B 88.38
Incyte (INCY) United States $13.528B 32.99
Exact Sciences (EXAS) United States $13.180B 0.00
Bio-Techne Corp (TECH) United States $11.214B 39.98
Bio-Rad Laboratories (BIO.B) United States $10.868B 30.51
Verona Pharma American Depositary Share (VRNA) United Kingdom $10.768B 0.00
Legend Biotech (LEGN) United States $10.604B 0.00
Sarepta Therapeutics (SRPT) United States $10.381B 0.00
Repligen (RGEN) United States $9.399B 64.34
QIAGEN (QGEN) Netherlands $9.204B 19.41
Roivant Sciences (ROIV) United Kingdom $7.972B 0.00
Sino Biopharmaceutical (SBMFF) Hong Kong, SAR China $6.961B 0.00
Exelixis (EXEL) United States $6.848B 42.18
Reata Pharmaceuticals (RETA) United States $6.570B 0.00
Karuna Therapeutics (KRTX) United States $6.543B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $5.888B 19.00
Apellis Pharmaceuticals (APLS) United States $5.714B 0.00
Ascendis Pharma (ASND) Denmark $5.464B 0.00
Halozyme Therapeutics (HALO) United States $5.224B 17.60
Intra-Cellular Therapies (ITCI) United States $5.222B 0.00
Alkermes (ALKS) Ireland $5.023B 251.33
Vaxcyte (PCVX) United States $4.725B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.895B 0.00
Ginkgo Bioworks Holdings (DNA) United States $3.841B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.697B 0.00
Insmed (INSM) United States $3.670B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.587B 0.00
Amicus Therapeutics (FOLD) United States $3.532B 0.00
Axsome Therapeutics (AXSM) United States $3.478B 0.00
Krystal Biotech (KRYS) United States $3.271B 0.00
Guardant Health (GH) United States $3.227B 0.00
Cytokinetics (CYTK) United States $3.069B 0.00
Blueprint Medicines (BPMC) United States $3.068B 0.00
Denali Therapeutics (DNLI) United States $3.054B 0.00
Intellia Therapeutics (NTLA) United States $3.008B 0.00
Prothena (PRTA) Ireland $2.811B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.754B 0.00
Akero Therapeutics (AKRO) United States $2.702B 0.00
Immunovant (IMVT) United States $2.692B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.587B 0.00
Fortrea Holdings (FTRE) United States $2.562B 0.00
Zai Lab (ZLAB) China $2.510B 0.00
Morphic Holding (MORF) United States $2.434B 0.00
Nuvalent (NUVL) United States $2.430B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.423B 0.00
Galapagos (GLPG) Belgium $2.350B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.299B 0.00
Certara (CERT) United States $2.285B 37.63
Harmony Biosciences Holdings (HRMY) United States $2.241B 12.45
Zealand Pharma (ZLDPF) Denmark $2.149B 0.00
Ventyx Biosciences (VTYX) United States $2.099B 0.00
Beam Therapeutics (BEAM) United States $1.998B 0.00
Mirati Therapeutics (MRTX) United States $1.904B 0.00
Bavarian Nordic (BVNRY) Denmark $1.779B 10.72
Rocket Pharmaceuticals (RCKT) United States $1.768B 0.00
Dynavax Technologies (DVAX) United States $1.737B 18.74
CureVac (CVAC) Germany $1.681B 0.00
Arcellx (ACLX) United States $1.669B 0.00
IDEAYA Biosciences (IDYA) United States $1.609B 0.00
NeoGenomics (NEO) United States $1.592B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $1.590B 0.00
Vericel (VCEL) United States $1.549B 0.00
SpringWorks Therapeutics (SWTX) United States $1.536B 0.00
Arcus Biosciences (RCUS) United States $1.475B 0.00
AbCellera Biologics (ABCL) Canada $1.470B 0.00
Myriad Genetics (MYGN) United States $1.392B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.367B 0.00
Viking Therapeutics (VKTX) United States $1.349B 0.00
Structure Therapeutics (GPCR) United States $1.336B 0.00
Iovance Biotherapeutics (IOVA) United States $1.301B 0.00
Arvinas (ARVN) United States $1.296B 0.00
Vir Biotechnology (VIR) United States $1.258B 0.00
Celldex Therapeutics (CLDX) United States $1.241B 0.00
Merus (MRUS) Netherlands $1.230B 0.00
ANI Pharmaceuticals (ANIP) United States $1.228B 19.65
Mirum Pharmaceuticals (MIRM) United States $1.190B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.188B 31.94
Biohaven (BHVN) United States $1.165B 0.00
Twist Bioscience (TWST) United States $1.159B 0.00
Revance Therapeutics (RVNC) United States $1.156B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.142B 0.00
89BIO (ETNB) United States $1.137B 0.00
Prime Medicine (PRME) United States $1.136B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.133B 0.00
Disc Medicine (IRON) United States $1.121B 0.00
Geron (GERN) United States $1.120B 0.00
MannKind (MNKD) United States $1.114B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.063B 0.00
Ligand Pharmaceuticals (LGND) United States $1.060B 23.49
Apogee Therapeutics (APGE) United States $1.056B 0.00
Keros Therapeutics (KROS) United States $0.993B 0.00
Replimune (REPL) United States $0.981B 0.00
Protagonist Therapeutics (PTGX) United States $0.978B 0.00
Pliant Therapeutics (PLRX) United States $0.977B 0.00
Travere Therapeutics (TVTX) United States $0.966B 0.00
Northwest Biotherapeutics (NWBO) United States $0.966B 0.00
Kymera Therapeutics (KYMR) United States $0.965B 0.00
ACELYRIN, INC (SLRN) United States $0.958B 0.00
Immatics (IMTX) Germany $0.926B 0.00
Pharming Group (PHAR) Netherlands $0.914B 0.00
MiMedx (MDXG) United States $0.903B 0.00
Tango Therapeutics (TNGX) United States $0.874B 0.00
Cytek Biosciences (CTKB) United States $0.863B 0.00
Inhibrx (INBX) United States $0.854B 0.00
Cogent Biosciences (COGT) United States $0.852B 0.00
Belite Bio (BLTE) United States $0.839B 0.00
Sana Biotechnology (SANA) United States $0.831B 0.00
Pharming Group (PHGUF) Netherlands $0.802B 0.00
ADMA Biologics Inc (ADMA) United States $0.798B 0.00
PureTech Health (PRTC) United States $0.778B 0.00
REGENXBIO (RGNX) United States $0.772B 0.00
ImmunityBio (IBRX) United States $0.764B 0.00
POINT Biopharma Global (PNT) United States $0.763B 8.29
Adaptive Biotechnologies (ADPT) United States $0.749B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.741B 0.00
Vera Therapeutics (VERA) United States $0.726B 0.00
Ambrx Biopharma (AMAM) United States $0.723B 0.00
Viridian Therapeutics (VRDN) United States $0.715B 0.00
Genelux (GNLX) United States $0.710B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.705B 13.95
Kura Oncology (KURA) United States $0.668B 0.00
Novavax (NVAX) United States $0.666B 0.00
Rapt Therapeutics (RAPT) United States $0.660B 0.00
Editas Medicine (EDIT) United States $0.649B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.649B 0.00
Sinovac Biotech (SVA) China $0.644B 0.00
Cabaletta Bio (CABA) United States $0.638B 0.00
Allogene Therapeutics (ALLO) United States $0.632B 0.00
Pharma Mar (PHMMF) Spain $0.621B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.617B 0.00
Tyra Biosciences (TYRA) United States $0.597B 0.00
Anavex Life Sciences (AVXL) United States $0.593B 0.00
Avid Bioservices (CDMO) United States $0.593B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.593B 0.00
HilleVax (HLVX) United States $0.571B 0.00
Repare Therapeutics (RPTX) Canada $0.548B 0.00
Tarsus Pharmaceuticals (TARS) United States $0.546B 0.00
Avidity Biosciences (RNA) United States $0.523B 0.00
WAVE Life Sciences (WVE) Singapore $0.521B 0.00
Alector (ALEC) United States $0.509B 0.00
Olema Pharmaceuticals (OLMA) United States $0.500B 0.00
Biomea Fusion (BMEA) United States $0.494B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.481B 0.00
AnaptysBio (ANAB) United States $0.478B 0.00
Entrada Therapeutics (TRDA) United States $0.471B 0.00
23andMe Holding (ME) United States $0.470B 0.00
Caribou Biosciences (CRBU) United States $0.465B 0.00
Agenus (AGEN) United States $0.455B 0.00
Oculis Holding AG (OCS) Switzerland $0.455B 0.00
Castle Biosciences (CSTL) United States $0.454B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.452B 0.00
Janux Therapeutics (JANX) United States $0.451B 0.00
Zymeworks (ZYME) United States $0.450B 2.37
Nurix Therapeutics (NRIX) United States $0.445B 0.00
Nautilus Biotechnology (NAUT) United States $0.439B 0.00
ITeos Therapeutics (ITOS) United States $0.438B 0.00
Oric Pharmaceuticals (ORIC) United States $0.436B 0.00
Coherus BioSciences (CHRS) United States $0.426B 0.00
Mineralys Therapeutics (MLYS) United States $0.415B 0.00
Icosavax (ICVX) United States $0.409B 0.00
Cullinan Oncology (CGEM) United States $0.407B 0.00
IGM Biosciences (IGMS) United States $0.407B 0.00
Liquidia Technologies (LQDA) United States $0.407B 0.00
Edgewise Therapeutics (EWTX) United States $0.393B 0.00
Scholar Rock Holding (SRRK) United States $0.391B 0.00
Amarin (AMRN) Ireland $0.384B 0.00
Aura Biosciences (AURA) United States $0.371B 0.00
Urogen Pharma (URGN) United States $0.370B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.363B 0.00
Aerovate Therapeutics (AVTE) United States $0.361B 0.00
Precigen (PGEN) United States $0.358B 0.00
UniQure (QURE) Netherlands $0.356B 0.00
Erasca (ERAS) United States $0.352B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.346B 0.00
Seres Therapeutics (MCRB) United States $0.342B 0.00
Voyager Therapeutics (VYGR) United States $0.338B 3.39
Bluebird Bio (BLUE) United States $0.337B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.336B 0.00
Arbutus Biopharma (ABUS) United States $0.335B 0.00
MaxCyte (MXCT) United States $0.328B 0.00
MeiraGTx Holdings (MGTX) United States $0.313B 0.00
Terns Pharmaceuticals (TERN) United States $0.313B 0.00
Apollomics (APLM) Taiwan $0.312B 0.00
Humacyte (HUMA) United States $0.304B 0.00
Inozyme Pharma (INZY) United States $0.302B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.300B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.297B 0.00
Nuvation Bio (NUVB) United States $0.296B 0.00
AN2 Therapeutics (ANTX) United States $0.289B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.284B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.284B 0.00
DBV Technologies S.A (DBVT) France $0.282B 0.00
Ovid Therapeutics (OVID) United States $0.279B 0.00
Fulcrum Therapeutics (FULC) United States $0.274B 0.00
Atea Pharmaceuticals (AVIR) United States $0.265B 0.00
ScPharmaceuticals (SCPH) United States $0.261B 0.00
Anika Therapeutics (ANIK) United States $0.260B 0.00
Zura Bio (ZURA) United States $0.259B 0.00
AC Immune (ACIU) Switzerland $0.258B 0.00
Scilex Holding (SCLX) United States $0.253B 0.00
Sagimet Biosciences (SGMT) United States $0.248B 0.00
Third Harmonic Bio (THRD) United States $0.246B 0.00
Lifecore Biomedical (LFCR) United States $0.246B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.246B 15.85
Compass Therapeutics (CMPX) United States $0.245B 0.00
Verastem (VSTM) United States $0.240B 0.00
Kamada (KMDA) Israel $0.237B 18.21
Nuvectis Pharma (NVCT) United States $0.235B 0.00
Immuneering (IMRX) United States $0.231B 0.00
Gracell Biotechnologies (GRCL) China $0.229B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.226B 0.00
Innate Pharma S.A (IPHA) France $0.226B 0.00
Vigil Neuroscience (VIGL) United States $0.222B 0.00
Fate Therapeutics (FATE) United States $0.222B 0.00
Celcuity (CELC) United States $0.220B 0.00
Akoya Biosciences (AKYA) United States $0.218B 0.00
Sutro Biopharma (STRO) United States $0.215B 0.00
Mesoblast (MESO) Australia $0.213B 0.00
Astria Therapeutics (ATXS) United States $0.213B 0.00
Gossamer Bio (GOSS) United States $0.200B 0.00
CorMedix Inc (CRMD) United States $0.199B 0.00
ALX Oncology Holdings (ALXO) United States $0.198B 0.00
TELA Bio (TELA) United States $0.198B 0.00
Inventiva S.A (IVA) France $0.198B 0.00
Renovaro Biosciences (RENB) United States $0.198B 0.00
Stoke Therapeutics (STOK) United States $0.197B 0.00
Praxis Precision Medicines (PRAX) United States $0.194B 0.00
Invivyd (IVVD) United States $0.192B 0.00
Emergent Biosolutions (EBS) United States $0.189B 0.00
Allakos (ALLK) United States $0.187B 0.00
GENFIT S.A (GNFT) France $0.185B 0.00
Vaxxinity (VAXX) United States $0.184B 0.00
Ikena Oncology (IKNA) United States $0.182B 0.00
XOMA (XOMA) United States $0.182B 0.00
Rallybio (RLYB) United States $0.181B 0.00
Tenaya Therapeutics (TNYA) United States $0.179B 0.00
Atara Biotherapeutics (ATRA) United States $0.178B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.176B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.175B 0.00
Prima BioMed (IMMP) Australia $0.174B 0.00
2seventy Bio (TSVT) United States $0.173B 0.00
Poseida Therapeutics (PSTX) United States $0.169B 0.00
X4 Pharmaceuticals (XFOR) United States $0.169B 0.00
Applied Therapeutics (APLT) United States $0.169B 0.00
LianBio (LIAN) United States $0.165B 0.00
Selecta Biosciences (SELB) United States $0.164B 0.00
Omega Therapeutics (OMGA) United States $0.164B 0.00
PDS Biotechnology (PDSB) United States $0.163B 0.00
Adverum Biotechnologies (ADVM) United States $0.163B 0.00
Molecular Partners AG (MOLN) Switzerland $0.161B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.160B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.156B 0.00
Oncolytics Biotech (ONCY) Canada $0.153B 0.00
Mersana Therapeutics (MRSN) United States $0.153B 0.00
Seer (SEER) United States $0.150B 0.00
InflaRx (IFRX) Germany $0.150B 0.00
Vor Biopharma (VOR) $0.149B 0.00
Sangamo Therapeutics (SGMO) United States $0.149B 0.00
Ocean Biomedical (OCEA) United States $0.142B 0.00
Absci (ABSI) United States $0.141B 0.00
Annexon (ANNX) United States $0.139B 0.00
Graphite Bio (GRPH) United States $0.139B 0.00
Trevi Therapeutics (TRVI) United States $0.138B 0.00
Puma Biotechnology (PBYI) United States $0.138B 0.00
Design Therapeutics (DSGN) United States $0.138B 0.00
Rani Therapeutics Holdings (RANI) United States $0.138B 0.00
XBiotech (XBIT) United States $0.136B 0.00
TScan Therapeutics (TCRX) United States $0.136B 0.00
Adocia (ADOCY) France $0.135B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.135B 0.00
Aadi Bioscience (AADI) United States $0.128B 0.00
PepGen (PEPG) United States $0.128B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.128B 0.00
Decibel Therapeutics (DBTX) United States $0.125B 0.00
Theseus Pharmaceuticals (THRX) United States $0.124B 0.00
Gritstone Bio (GRTS) United States $0.121B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.120B 0.00
Eton Pharmaceuticals (ETON) United States $0.119B 0.00
INmune Bio (INMB) United States $0.119B 0.00
Codexis (CDXS) United States $0.119B 0.00
DiaMedica Therapeutics (DMAC) United States $0.113B 0.00
Greenwich LifeSciences (GLSI) United States $0.113B 0.00
Kodiak Sciences (KOD) United States $0.110B 0.00
C4 Therapeutics (CCCC) United States $0.109B 0.00
Bionano Genomics (BNGO) United States $0.106B 0.00
Genenta Science S.p.A (GNTA) Italy $0.106B 0.00
Opthea (OPT) Australia $0.105B 0.00
Cue Biopharma (CUE) United States $0.105B 0.00
Inovio Pharmaceuticals (INO) United States $0.105B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.104B 0.00
ChromaDex (CDXC) United States $0.104B 0.00
I-Mab (IMAB) China $0.103B 0.00
Cidara Therapeutics (CDTX) United States $0.103B 0.00
MediciNova (MNOV) United States $0.103B 0.00
Gamida Cell (GMDA) United States $0.102B 0.00
Ocugen (OCGN) United States $0.101B 0.00
Graf Acquisition IV (GFOR) United States $0.101B 0.00
NGM Biopharmaceuticals (NGM) United States $0.101B 0.00
Spruce Biosciences (SPRB) United States $0.100B 0.00
Armata Pharmaceuticals (ARMP) United States $0.099B 0.00
PhenomeX (CELL) United States $0.098B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.098B 0.00
Cara Therapeutics (CARA) United States $0.097B 0.00
Annovis Bio (ANVS) United States $0.096B 0.00
BioAtla (BCAB) United States $0.096B 0.00
Turnstone Biologics (TSBX) United States $0.094B 0.00
Abeona Therapeutics (ABEO) United States $0.094B 0.00
BRIACELL THERAP (BCTX) Canada $0.094B 0.00
ATyr Pharma (LIFE) United States $0.092B 0.00
IO Biotech (IOBT) Denmark $0.092B 0.00
CytomX Therapeutics (CTMX) United States $0.091B 0.00
Cellectis S.A (CLLS) France $0.091B 0.00
Beyond Air (XAIR) United States $0.090B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.089B 0.00
BioXcel Therapeutics (BTAI) United States $0.088B 0.00
Compugen (CGEN) Israel $0.088B 0.00
Immunome (IMNM) United States $0.087B 0.00
Evelo Biosciences (EVLO) United States $0.087B 0.00
Jasper Therapeutics (JSPR) United States $0.085B 0.00
Data Knights Acquisition (DKDCA) United Kingdom $0.085B 0.00
Werewolf Therapeutics (HOWL) United States $0.084B 0.00
Ocuphire Pharma (OCUP) United States $0.083B 4.71
Nkarta (NKTX) United States $0.083B 0.00
Kezar Life Sciences (KZR) United States $0.083B 0.00
Genetron Holdings (GTH) China $0.081B 0.00
Syros Pharmaceuticals (SYRS) United States $0.081B 0.00
Sorrento Therapeutics (SRNEQ) United States $0.081B 0.00
Athira Pharma (ATHA) United States $0.078B 0.00
Kronos Bio (KRON) United States $0.076B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.075B 0.00
HCW Biologics (HCWB) United States $0.075B 0.00
Cardiff Oncology (CRDF) United States $0.073B 0.00
Elicio Therapeutics (ELTX) United States $0.073B 0.00
Affimed (AFMD) Germany $0.073B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.072B 0.00
Kinnate Biopharma (KNTE) United States $0.071B 0.00
Shattuck Labs (STTK) United States $0.071B 0.00
G1 Therapeutics (GTHX) United States $0.069B 0.00
Enzo Biochem (ENZ) United States $0.069B 0.00
Adicet Bio (ACET) United States $0.069B 0.00
AVROBIO (AVRO) United States $0.068B 0.00
Prenetics Global (PRE) Cayman Islands $0.067B 1.57
Immunic (IMUX) United States $0.066B 0.00
Spero Therapeutics (SPRO) United States $0.065B 0.00
Vaccitech (VACC) United Kingdom $0.065B 0.00
Eyenovia (EYEN) United States $0.063B 0.00
Adagene (ADAG) China $0.062B 0.00
Xilio Therapeutics (XLO) United States $0.062B 0.00
Clene (CLNN) United States $0.062B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.059B 0.00
Solid Biosciences (SLDB) United States $0.057B 0.00
Oncobiologics (OTLK) United States $0.056B 0.00
Instil Bio (TIL) United States $0.055B 0.00
AEON Biopharma (AEON) United States $0.055B 0.00
Dyadic (DYAI) United States $0.055B 0.00
Intensity Therapeutics (INTS) United States $0.053B 0.00
Alpha Teknova (TKNO) United States $0.053B 0.00
Theratechnologies (THTX) Canada $0.052B 0.00
Clearside Biomedical (CLSD) United States $0.051B 0.00
HOOKIPA Pharma (HOOK) United States $0.051B 0.00
Curis (CRIS) United States $0.051B 0.00
OKYO Pharma (OKYO) $0.051B 0.00
Rezolute (RZLT) United States $0.050B 0.00
Dianthus Therapeutics (DNTH) United States $0.050B 0.00
Precision BioSciences (DTIL) United States $0.049B 0.00
Immix Biopharma (IMMX) United States $0.049B 0.00
VistaGen Therapeutics (VTGN) United States $0.049B 0.00
Portage Biotech (PRTG) $0.046B 0.00
MiNK Therapeutics (INKT) United States $0.046B 0.00
Longeveron (LGVN) United States $0.046B 0.00
Fortress Biotech (FBIO) United States $0.044B 0.00
VTv Therapeutics (VTVT) United States $0.044B 0.00
Quince Therapeutics (QNCX) United States $0.044B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.044B 0.00
Celularity (CELU) United States $0.044B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.044B 0.00
Galena Biopharma (SLS) United States $0.043B 0.00
Lantern Pharma (LTRN) United States $0.042B 0.00
Bolt Biotherapeutics (BOLT) United States $0.041B 0.00
Science 37 Holdings (SNCE) United States $0.040B 0.00
Dare Bioscience (DARE) United States $0.040B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.039B 0.00
Coya Therapeutics (COYA) United States $0.039B 0.00
Connect Biopharma Holdings (CNTB) United States $0.039B 0.00
Mainz Biomed (MYNZ) Germany $0.039B 0.00
Seelos Therapeutics (SEEL) United States $0.039B 0.00
Cognition Therapeutics (CGTX) United States $0.038B 0.00
Passage Bio (PASG) United States $0.038B 0.00
NextCure (NXTC) United States $0.037B 0.00
Miromatrix Medical (MIRO) United States $0.037B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.037B 0.00
IN8bio (INAB) United States $0.037B 0.00
Checkpoint Therapeutics (CKPT) United States $0.036B 0.00
UNITY Biotechnology (UBX) United States $0.036B 0.00
Leap Therapeutics (LPTX) United States $0.036B 0.00
Telesis Bio (TBIO) United States $0.036B 0.00
Aligos Therapeutics (ALGS) United States $0.034B 0.00
NuCana (NCNA) United Kingdom $0.034B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.033B 0.00
Candel Therapeutics (CADL) United States $0.033B 0.00
Neoleukin Therapeutics (NLTX) United States $0.033B 0.00
Biora Therapeutics (BIOR) United States $0.032B 0.00
BeyondSpring (BYSI) United States $0.031B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.031B 0.00
Cyclo Therapeutics (CYTH) United States $0.031B 0.00
Rain Oncology (RAIN) United States $0.031B 0.00
Axcella Health (AXLA) United States $0.031B 0.00
Elevation Oncology (ELEV) United States $0.031B 0.00
SAB Biotherapeutics (SABS) United States $0.030B 0.00
Forte Biosciences (FBRX) United States $0.029B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.029B 0.00
Evogene (EVGN) Israel $0.028B 0.00
Alimera Sciences (ALIM) United States $0.027B 0.00
Equillium (EQ) United States $0.027B 0.00
KALA BIO (KALA) United States $0.027B 0.00
GENPREX (GNPX) United States $0.027B 0.00
TradeUP Acquisition (UPTD) United States $0.027B 0.00
Liminal BioSciences (LMNL) Canada $0.026B 0.00
Elutia (ELUT) United States $0.026B 0.00
Pluri (PLUR) Israel $0.025B 0.00
Aptose Biosciences (APTO) Canada $0.024B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.024B 0.00
Synlogic (SYBX) United States $0.023B 0.00
Lumos Pharma (LUMO) United States $0.023B 0.00
Sensei Biotherapeutics (SNSE) United States $0.023B 0.00
YS Biopharma (YS) China $0.022B 1.09
EFFECTOR Therapeutics (EFTR) United States $0.022B 0.00
Alzamend Neuro (ALZN) United States $0.022B 0.00
Kineta (KA) United States $0.022B 0.00
Azitra (AZTR) United States $0.022B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.021B 0.00
Senti Biosciences (SNTI) United States $0.021B 0.00
Medicenna Therapeutics (MDNA) Canada $0.021B 0.00
Catalyst Biosciences (CBIO) United States $0.021B 0.00
Cocrystal Pharma (COCP) United States $0.020B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.020B 0.00
Entera Bio (ENTX) Israel $0.020B 0.00
Mustang Bio (MBIO) United States $0.020B 0.00
Virios Therapeutics (VIRI) United States $0.020B 0.00
Acorda Therapeutics (ACOR) United States $0.019B 0.00
Purple Biotech (PPBT) Israel $0.019B 0.00
Evaxion Biotech (EVAX) Denmark $0.019B 0.00
Vincerx Pharma (VINC) United States $0.018B 0.00
Edesa Biotech (EDSA) Canada $0.018B 0.00
Promis Neurosciences (PMN) Canada $0.018B 0.00
PHAXIAM Therapeutics S.A (PHXM) France $0.017B 0.00
AquaBounty Technologies (AQB) United States $0.017B 0.00
Vascular Biogenics (VBLT) Israel $0.017B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.017B 0.00
VBI Vaccines (VBIV) United States $0.017B 0.00
Orgenesis (ORGS) United States $0.017B 0.00
Freeline Therapeutics Holdings (FRLN) United Kingdom $0.017B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Genetic Technologies (GENE) Australia $0.016B 0.00
Aprea Therapeutics (APRE) United States $0.016B 0.00
Lisata Therapeutics (LSTA) United States $0.016B 0.00
Galecto (GLTO) Denmark $0.016B 0.00
ZIVO Bioscience (ZIVO) United States $0.015B 0.00
Senesco Technologies (ELOX) United States $0.015B 0.00
CalciMedica (CALC) United States $0.015B 0.00
RenovoRx (RNXT) United States $0.015B 0.00
Frequency Therapeutics (FREQ) United States $0.014B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.014B 0.00
GeoVax Labs (GOVX) United States $0.014B 0.00
BioAffinity Technologies (BIAF) United States $0.014B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.013B 0.00
Organovo Holdings (ONVO) United States $0.013B 0.00
AEterna Zentaris (AEZS) Canada $0.013B 0.00
Atreca (BCEL) United States $0.013B 0.00
Pasithea Therapeutics (KTTA) United States $0.012B 0.00
TFF Pharmaceuticals (TFFP) United States $0.012B 0.00
Landos Biopharma (LABP) United States $0.012B 0.00
Biofrontera (BFRI) United States $0.012B 0.00
Cingulate (CING) United States $0.012B 0.00
Moleculin Biotech (MBRX) United States $0.011B 0.00
Chemomab Therapeutics (CMMB) Israel $0.011B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Eterna Therapeutics (ERNA) United States $0.011B 0.00
ARAVIVE, INC (ARAV) United States $0.011B 0.00
Avalon GloboCare (ALBT) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Talis Biomedical (TLIS) United States $0.011B 0.00
Vaccinex (VCNX) United States $0.010B 0.00
Imunon (IMNN) United States $0.010B 0.00
GT Biopharma (GTBP) United States $0.010B 0.00
Sunshine Biopharma (SBFM) Canada $0.010B 0.00
Trevena (TRVN) United States $0.009B 0.00
Cadrenal Therapeutics (CVKD) United States $0.009B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.009B 0.00
Blue Water Biotech (BWV) United States $0.009B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.009B 0.00
Comera Life Sciences Holdings (CMRA) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Bionomics (BNOX) Australia $0.009B 0.00
Cohbar (CWBR) United States $0.008B 0.00
BioCardia (BCDA) United States $0.008B 0.00
Monopar Therapeutics (MNPR) United States $0.008B 0.00
Galera Therapeutics (GRTX) United States $0.008B 0.00
Applied Molecular Transport (AMTI) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Atrinsic (PTIX) United States $0.008B 0.00
Biorestorative Therapies (BRTX) United States $0.008B 0.00
Kintara Therapeutics (KTRA) United States $0.008B 0.00
Lexaria Bioscience (LEXX) Canada $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Aileron Therapeutics (ALRN) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Athersys (ATHX) United States $0.007B 0.00
CervoMed (CRVO) United States $0.007B 0.00
TRACON Pharmaceuticals (TCON) United States $0.007B 0.00
Bright Minds Biosciences (DRUG) United States $0.006B 0.00
Exicure (XCUR) United States $0.006B 0.44
Aytu BioPharma (AYTU) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
NexImmune (NEXI) United States $0.006B 0.00
Bellerophon Therapeutics (BLPH) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Biophytis SA (BPTS) France $0.005B 0.00
Windtree Therapeutics (WINT) United States $0.005B 0.00
PaxMedica (PXMD) United States $0.005B 0.00
Femasys (FEMY) United States $0.005B 0.00
Benitec Biopharma (BNTC) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Revelation Biosciences (REVB) United States $0.005B 0.00
GRI Bio (GRI) United States $0.005B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Hillstream BioPharma (HILS) United States $0.004B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.004B 0.00
ABVC BioPharma (ABVC) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.04
Aptevo Therapeutics (APVO) United States $0.004B 0.00
Panbela Therapeutics (PBLA) United States $0.004B 0.00
180 Life Sciences (ATNF) United States $0.004B 0.30
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Aceragen (ACGN) United States $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
ThermoGenesis Holdings (THMO) United States $0.003B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
NeuBase Therapeutics (NBSE) United States $0.003B 0.00
First Wave BioPharma (FWBI) United States $0.003B 0.07
Invo BioScience (INVO) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
MorphoSys AG (MOR) Germany $0.000B 18.37
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
ARCA Biopharma (ABIO) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
GH Research (GHRS) Ireland $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00